AustralianSuper Pty Ltd Purchases 8,333 Shares of Mettler-Toledo International, Inc. $MTD

AustralianSuper Pty Ltd boosted its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 7.0% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 126,734 shares of the medical instruments supplier’s stock after acquiring an additional 8,333 shares during the period. Mettler-Toledo International accounts for approximately 0.7% of AustralianSuper Pty Ltd’s portfolio, making the stock its 27th largest holding. AustralianSuper Pty Ltd’s holdings in Mettler-Toledo International were worth $155,580,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the business. Bank of New York Mellon Corp lifted its stake in shares of Mettler-Toledo International by 71.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock valued at $1,062,257,000 after buying an additional 376,419 shares in the last quarter. Norges Bank bought a new stake in Mettler-Toledo International during the 2nd quarter valued at $360,126,000. Rakuten Investment Management Inc. purchased a new stake in shares of Mettler-Toledo International during the third quarter worth $121,021,000. Corient Private Wealth LLC boosted its holdings in shares of Mettler-Toledo International by 91.8% in the second quarter. Corient Private Wealth LLC now owns 140,267 shares of the medical instruments supplier’s stock worth $164,775,000 after acquiring an additional 67,149 shares during the period. Finally, Fiera Capital Corp grew its position in shares of Mettler-Toledo International by 19.0% in the second quarter. Fiera Capital Corp now owns 342,837 shares of the medical instruments supplier’s stock valued at $402,737,000 after purchasing an additional 54,740 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Stock Performance

MTD stock opened at $1,400.86 on Thursday. The firm has a market cap of $28.62 billion, a P/E ratio of 34.93, a P/E/G ratio of 4.24 and a beta of 1.41. The firm’s fifty day moving average is $1,434.10 and its 200 day moving average is $1,350.38. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating the consensus estimate of $10.62 by $0.53. The company had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.Mettler-Toledo International’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the prior year, the business posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. As a group, analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Insiders Place Their Bets

In related news, insider La Guerroniere Marc De sold 6,055 shares of the stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $1,488.18, for a total value of $9,010,929.90. Following the completion of the transaction, the insider directly owned 187 shares of the company’s stock, valued at $278,289.66. This represents a 97.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Shawn Vadala sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $1,511.00, for a total value of $1,511,000.00. Following the completion of the transaction, the chief financial officer owned 5,288 shares of the company’s stock, valued at approximately $7,990,168. The trade was a 15.90% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 19,565 shares of company stock worth $28,683,737. Insiders own 0.77% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Citigroup increased their price target on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Mettler-Toledo International in a report on Monday, December 29th. Wall Street Zen raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Monday, January 19th. Bank of America upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target for the company in a research report on Monday, December 15th. Finally, Barclays lowered their price objective on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research report on Monday, December 15th. Six research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $1,441.67.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.